References
- Bateman E D, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143–178
- Toogood J H. Complications of topical steroid therapy for asthma. Rev Respir Dis 1990; 141: S89–96
- Simon M R, Houser W L, Smith K A, Long P M. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol 1997; 79: 333–338
- Guidelines for the Diagnosis and Management of Asthma. 2007, Expert Panel Report 3. National Institutes of Health (section on ICS local adverse effects)
- Kanda N, Yasuba H, Takahashi T, Mizuhara Y, Yamazaki S, Imada Y, Izumi Y, Kobayashi Y, Yamashita K, Kita H, Tamada T, Chiba T. Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate. Am J Gastroenterol 2003; 98(10)2146–2148
- Shuto H, Nagata M, Terashi Y, Yamaguchi M, Takizawa T, Shuto C, Watanabe K, Tosaka K, Okano M, Noguchi H. Esophageal candidiasis as complication of inhaled steroid therapy. Arerugi 2003; 52(11)1053–1064
- Kobayashi Y, Yasuba H, Kudou M, Hamada K, Kita H. Esophageal candidiasis as a side effect of inhaled fluticasone propionate dry powder: recovery by switching over to hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP). Int J Clin Pharmacol Ther 2006; 44(5)193–197
- Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003; 90(6)646–651
- Stein M R, Shay S S, Jacobson K. Monilial asophagitis in asthmatic patients treated with beclomethasone. J Allergy Clin Immunol 1979; 63: 172
- Hemstreet M P, Reynolds D W, Meadows J, Jr. Oesophagitis – a complication of inhaled steroid therapy. Clin Allergy 1980; 10: 733–738
- Kesten S, Hyland R H, Pruzanski W R, Kortan P P. Esophageal candidiasis associated with beclomethasone dipropionate aerosol therapy. Drug Intell Clin Pharm 1988; 22(7–8)568–569
- Sievert W, Holmes P, King R W. Oesophageal candidosis in patients on high-dose inhaled steroids. Lancet 1992; 339(8808)1551–1552
- Toogood J H, Baskerville J, Jennings B, Lefcoe N M, Johansson S A. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984; 129(5)723–729
- Salzman G A, Pyszczynski D R. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with aerochamber. J Allergy Clin Immunol 1988; 81(2)424–428
- Mullaoglu S, Turktas H, Kokturk N, Tuncer C, Kalkanci A, Kustimur S. Esophageal candidiasis and Candida colonization in asthma patients on inhaled steroids. Allergy Asthma Proc 2007; 28(5)544–549
- Lipworth R J. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995; 50: 105–110
- Leach C L, Davidson P J, Bredow T S, Boudreau R J. Patient factors influencing the deposition of HFA-beclomethasone dipropionate metered dose inhaler. Eur Respir J 1998a; 12: 66s